Bowhead Specialty Holdings Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.420 |
| EPS actual | $0.480 |
| EPS Surprise | 14.29% |
| Revenue estimate | 211.742M |
| Revenue actual | 216.741M |
| Revenue Surprise | 2.36% |
| Release date | Feb 24, 2026 |
| EPS estimate | $0.450 |
| EPS actual | $0.470 |
| EPS Surprise | 4.44% |
| Revenue estimate | 216.656M |
| Revenue actual | 224.081M |
| Revenue Surprise | 3.43% |
| Release date | Nov 04, 2025 |
| EPS estimate | $0.400 |
| EPS actual | $0.470 |
| EPS Surprise | 17.50% |
| Revenue estimate | 145.986M |
| Revenue actual | 143.9M |
| Revenue Surprise | -1.43% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.360 |
| EPS actual | $0.370 |
| EPS Surprise | 2.78% |
| Revenue estimate | 142.032M |
| Revenue actual | 133.263M |
| Revenue Surprise | -6.17% |
Last 4 Quarters for Bowhead Specialty Holdings
Below you can see how BOW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $31.15 |
| EPS estimate | $0.360 |
| EPS actual | $0.370 |
| EPS surprise | 2.78% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $31.99 |
| Jul 31, 2025 | $32.50 |
| Aug 01, 2025 | $31.92 |
| Aug 04, 2025 | $32.42 |
| Aug 05, 2025 | $31.15 |
| Aug 06, 2025 | $32.10 |
| Aug 07, 2025 | $31.23 |
| Aug 08, 2025 | $31.00 |
| Aug 11, 2025 | $31.60 |
| 4 days before | -2.63% |
| 4 days after | 1.44% |
| On release day | 3.05% |
| Change in period | -1.22% |
| Release date | Nov 04, 2025 |
| Price on release | $25.45 |
| EPS estimate | $0.400 |
| EPS actual | $0.470 |
| EPS surprise | 17.50% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $24.10 |
| Oct 30, 2025 | $24.21 |
| Oct 31, 2025 | $23.96 |
| Nov 03, 2025 | $24.35 |
| Nov 04, 2025 | $25.45 |
| Nov 05, 2025 | $25.92 |
| Nov 06, 2025 | $25.07 |
| Nov 07, 2025 | $25.87 |
| Nov 10, 2025 | $26.52 |
| 4 days before | 5.60% |
| 4 days after | 4.20% |
| On release day | 1.85% |
| Change in period | 10.04% |
| Release date | Feb 24, 2026 |
| Price on release | $24.36 |
| EPS estimate | $0.450 |
| EPS actual | $0.470 |
| EPS surprise | 4.44% |
| Date | Price |
|---|---|
| Feb 18, 2026 | $24.25 |
| Feb 19, 2026 | $24.56 |
| Feb 20, 2026 | $24.90 |
| Feb 23, 2026 | $24.79 |
| Feb 24, 2026 | $24.36 |
| Feb 25, 2026 | $26.16 |
| Feb 26, 2026 | $25.04 |
| Feb 27, 2026 | $25.33 |
| Mar 02, 2026 | $25.57 |
| 4 days before | 0.454% |
| 4 days after | 4.97% |
| On release day | 7.39% |
| Change in period | 5.44% |
| Release date | May 05, 2026 |
| Price on release | $25.07 |
| EPS estimate | $0.420 |
| EPS actual | $0.480 |
| EPS surprise | 14.29% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $23.87 |
| Apr 30, 2026 | $23.78 |
| May 01, 2026 | $24.32 |
| May 04, 2026 | $23.28 |
| May 05, 2026 | $25.07 |
| May 06, 2026 | $24.72 |
| May 07, 2026 | $26.36 |
| May 08, 2026 | $27.06 |
| May 11, 2026 | $27.87 |
| 4 days before | 5.03% |
| 4 days after | 11.17% |
| On release day | -1.40% |
| Change in period | 16.76% |
Bowhead Specialty Holdings Earnings Call Transcript Summary of Q1 2026
Bowhead Specialty reported a strong start to 2026 with gross written premiums (GWP) up 24% year-over-year to ~$217 million, driven primarily by casualty (GWP +20% to $147M) and growth in Healthcare Liability (+28%). Digital underwriting (Baleen Specialty + Bowhead Express) is an early but accelerating contributor (~7% of GWP in Q1), with Baleen generating >$11M of premium (3x YoY) and Express >$3M. Adjusted net income was $16M (up ~40% YoY), diluted adjusted EPS $0.48, adjusted return on average equity 14.1%, and a combined ratio of 95.3%. Loss ratio was 66.9% (flat YoY); expense ratio improved to 28.4% (down ~2 pts YoY) partly from scaling and a timing item in deferrable costs. Investment income rose ~44% YoY to $18M; portfolio book yield ~4.6% and AA- credit quality. On May 1 reinsurance renewals, quota share ceded increased from 26% to 33.5% and excess-of-loss placement declined (65% to 57.5%); renewals placed with A-rated or better reinsurers. Management emphasizes disciplined underwriting (craft + digital platforms), continued scaling of digital products (broker expansion and product roadmap), and that digital economics should produce lower expense ratios as scale is achieved. Capital position was bolstered by a $150M debt raise in late 2025 and expanded American Family support (raising the prior $1B GWP cap); management expects capital and reinsurance structure to be neutral to near-term earnings while supporting ~20% growth. Key near-term drivers to monitor: continued digital growth and underwriting performance of Baleen/Express, casualty market pricing and mix (excess casualty favorable), healthcare liability exposure (sexual abuse/molestation dynamics), expense trend normalization, and impacts from reinsurance changes on net earned premium and cash flows.
Sign In
Buy BOW